Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:DEPO

Depomed (DEPO) Stock Price, News & Analysis

Depomed logo

About Depomed Stock (NASDAQ:DEPO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$7.09
$7.42
50-Day Range
N/A
52-Week Range
$4.31
$9.48
Volume
940,193 shs
Average Volume
1.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Remove Ads
Receive DEPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Depomed and its competitors with MarketBeat's FREE daily newsletter.

DEPO Stock News Headlines

Pfizer: Investor Activism Is Not The Solution
DOGE could send 6 AI stocks through the roof
Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.
Why DepoMed (DEPO) Stock Is Gaining Today
Opioid Litigants Get Boost From Senate Report
See More Headlines

DEPO Stock Analysis - Frequently Asked Questions

Depomed, Inc. (NASDAQ:DEPO) posted its quarterly earnings data on Wednesday, August, 8th. The specialty pharmaceutical company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.03. The firm's revenue was down 37.0% compared to the same quarter last year.

Company Calendar

Last Earnings
8/08/2018
Today
3/28/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:DEPO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:DEPO) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners